Yarbrough Capital’s Bristol-Myers Squibb BMY Stock Holding History

Yarbrough Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,400	Closed	-$383K	–	194
2024 Q3	$383K	Hold	7,400	–	–	0.02%	161
2024 Q2	$307K	Hold	7,400	–	–	0.01%	168
2024 Q1	$401K	Hold	7,400	–	–	0.02%	154
2023 Q4	$380K	Hold	7,400	–	–	0.02%	164
2023 Q3	$429K	Hold	7,400	–	–	0.03%	136
2023 Q2	$473K	Hold	7,400	–	–	0.03%	140
2023 Q1	$513K	Hold	7,400	–	–	0.04%	125
2022 Q4	$532K	Hold	7,400	–	–	0.04%	95
2022 Q3	$526K	Hold	7,400	–	–	0.04%	106
2022 Q2	$570K	Hold	7,400	–	–	0.04%	100
2022 Q1	$540K	Hold	7,400	–	–	0.03%	126
2021 Q4	$461K	Buy	+7,400	New	+$434K	0.02%	148

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return